Medimap Funding: How Much Did They Raise & Key Investors

How Much Did Medimap Raise?
Funding & Key Investors

Medimap, a prominent player in the Canadian digital health landscape, has successfully secured a major strategic investment, bringing its total capital accumulation to $2.8M. This latest infusion of $2.8M underscores the company's pivotal role in modernizing patient access to care. By facilitating real-time transparency for medical wait times, Medimap has established itself as a critical bridge between healthcare providers and patients seeking immediate attention. The recent financing round reflects strong investor confidence in the company's ability to scale its platform across the North American healthcare ecosystem.

Since its inception in 2015, Medimap has demonstrated a consistent growth trajectory, evolving from a niche resource into a comprehensive digital health utility. The current capital injection serves as a catalyst for further expansion, enabling the firm to enhance its virtual care connectivity and broaden its reach within the competitive health-tech sector.

What is Medimap?

Medimap

Software

Healthcare Software

Mobile App Development

Headquartered in Vancouver, British Columbia, Medimap operates a sophisticated digital platform that provides real-time, same-day access to medical care. The company serves as a vital intermediary for over 1,200 medical clinics across Canada, allowing them to publish live wait times and facilitate virtual patient consultations. By addressing the systemic inefficiencies in primary care accessibility, Medimap has carved out a significant market position, effectively digitizing the patient intake experience and optimizing clinic throughput. Its business model is centered on transparency and operational efficiency, providing a seamless interface that benefits both healthcare practitioners and the general public.

How much funding has Medimap raised?

Medimap has raised a total of $2.8M across 1 funding round:

2021

Angel/Seed

$2.8M

Angel/Seed (2021): $2.8M with participation from David Arnsdorf, Rajiv Khaneja, Rasool Rayani, and Tiny Capital

Key Investors in Medimap

Tiny Capital

A Victoria-based investment firm that utilizes permanent capital to support long-term business growth, focusing on management-friendly partnerships and value-oriented acquisitions.

David Arnsdorf

An individual investor participating in the strategic financing round to support the expansion of digital health infrastructure.

Rajiv Khaneja

An individual investor providing capital to fuel the growth and operational scaling of Medimap's real-time care platform.

What's next for Medimap?

With this major enterprise-level funding, Medimap is well-positioned to accelerate its product development and market penetration. The strategic focus will likely shift toward enhancing the platform's virtual care capabilities and integrating more deeply with existing electronic health record systems. As the demand for digital-first healthcare solutions continues to rise, Medimap's ability to leverage its existing network of clinics will be paramount in maintaining its competitive advantage. Future growth initiatives will likely prioritize scaling operations to accommodate higher user volumes and exploring potential cross-border opportunities, ensuring the company remains at the forefront of the digital health transformation.

See full Medimap company page

See More Financial Insights